Scarica l'app Stockscreener
5.12
0.59%
0.03
Pre-mercato:
5.11
-0.010
-0.20%
Third Harmonic Bio Inc Borsa (THRD) Ultime notizie
Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties - TipRanks
Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals
Third Harmonic Bio leaps as it reveals liquidation plan - The Pharma Letter
Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals
Top 3 Health Care Stocks You May Want To Dump This Quarter - Benzinga
Third Harmonic Bio Announces Liquidation Plan: Stock Skyrockets 39% Pre-Market, But Retail’s Shattered - MSN
$26bn Brighton Jones hires new CFO - Citywire
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Third Harmonic outlines plans for dissolution - BioPharma Dive
Third Harmonic Bio sees initial distribution of $5.13-$5.33 from liquidation - TipRanks
Third Harmonic Bio plans to liquidate the company, sell urticaria treatment - Seeking Alpha
Third Harmonic Bio Stock Is Up 40% Monday: What's Happening? - Benzinga
Third Harmonic Bio plans liquidation and asset sale By Investing.com - Investing.com Canada
Third Harmonic Announces Liquidation And Cash Return, Stock Jumps - Nasdaq
Third Harmonic to shutter; Future Pak once again targets Theratechnologies - Endpoints News
Third Harmonic Bio Plans Liquidation With Lucrative Payouts - Finimize
Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Third Harmonic Bio announces plan of liquidation and dissolution - TipRanks
Third Harmonic Bio Announces Plan Of Liquidation And Dissolution - MarketScreener
Third Harmonic Bio Announces Plan of Liquidation and Dissolution - The Manila Times
Third Harmonic Bio plans liquidation and asset sale - Investing.com
Third Harmonic Bio to Return $255M to Shareholders in Major Cash Distribution - Stock Titan
Layoff Tracker: Opthea Slashes 65% of Staff, Pfizer Cuts 56 - BioSpace
Fierce Biotech Layoff Tracker 2025: Opthea reduces workforce by 65%; Organon lays off 93 staffers - Fierce Biotech
Third Harmonic stock rating cut by Raymond James - MSN
Third Harmonic Bio initiates process to identify opportunities to maximize value - TipRanks
Hold Rating for Third Harmonic Bio, Inc. Amid Strategic Exploration and Cautious Development Approach - TipRanks
Stifel Downgrades Third Harmonic Bio (THRD) - MSN
Stifel Nicolaus Downgrades Third Harmonic Bio to Neutral From Buy, Adjusts Price Target to $5 From $23 - MarketScreener
Third Harmonic Bio Reports 2024 Financial Results and Strategic Plans - TipRanks
Third Harmonic Bio reports FY24 EPS ($1.09) vs. (78c) last year - TipRanks
Stifel cuts Third Harmonic stock rating to hold, slashes target to $5 - Investing.com
Third Harmonic Bio Q4 Net Income USD -13.1 Million - Marketscreener.com
Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
BIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ET - The Manila Times
Third Harmonic Bio, Inc. Announces Rise In Full Year Profit - Nasdaq
Third Harmonic's $285M War Chest Powers Phase 2 CSU Drug Development Amid Strategic Shift - Stock Titan
Third Harmonic Bio Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
2025 R&D layoffs tracker: 53,686 and counting - R&D World
Flagship startup raises $200M in pursuit of ‘scientific superintelligence’ - BioPharma Dive
Third Harmonic Bio Advances THB335 for Inflammatory Diseases - TipRanks
THB-335 counteracts cutaneous anaphylaxis in vivo - BioWorld Online
0.98%
5.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):